Background Coronavirus disease 2019(COVID-19) has spread worldwide. The present study aimed to characterize the clinical features and outcomes of imported COVID-19 patients with high body mass index (BMI) and the independent association of BMI with disease severity. Methods In this retrospective cohort study, 455 imported COVID-19 patients were admitted and discharged in Zhejiang province by February 28, 2020. Epidemiological, demographic, clinical, laboratory, radiological, treatment, and outcome data were collected, analyzed and compared between patients with BMI ≥ 24and < 24. Results A total of 268 patients had BMI < 24, and 187 patients had BMI ≥ 24. Those with high BMI were mostly men, had a smoking history, fever, cough, and sputum than those with BMI < 24. A large number of patients with BMI ≥ 24 were diagnosed as severe/critical types. Some biochemical indicators were significantly elevated in patients with BMI ≥ 24. Also, acute liver injury was the most common complication in these patients. The median days from illness onset to severe acute respiratory syndrome coronavirus 2 detection, duration of hospitalization, and days from illness onset to discharge were significantly longer in patients with BMI ≥ 24 than those with BMI < 24. High BMI, exposure to Wuhan, any coexisting medical condition, high temperature, C-reactive protein (CRP), and increased lactate dehydrogenase (LDH) were independent risk factors for severe/critical COVID-19. After adjusting for age, sex and above factors, BMI was still independently associated with progression to severe/critical illness ( P = 0.0040). Hemoglobin, alanine aminotransferase (ALT), CRP, and serum creatinine (Scr) were independent risk factors associated with high BMI. Conclusions Contrasted with the imported COVID-19 patients with BMI < 24, high proportion of COVID-19 patients with BMI ≥ 24 in our study, especially those with elevated CRP and LDH, developed to severe type, with longer hospitalization duration and anti-virus course. Thus, high BMI is a risk factor for the progression and prognosis of imported COVID-19. Supplementary Information The online version contains supplementary material available at 10.1186/s12879-021-05818-0.
【저자키워드】 COVID-19, Prognosis, progression, risk factor, High BMI, 【초록키워드】 Treatment, coronavirus disease, Coronavirus disease 2019, coronavirus, Prognosis, Hospitalization, disease severity, LDH, Sex, C-reactive protein, CRP, outcome, smoking, risk factor, severe acute respiratory syndrome Coronavirus, cough, sputum, lactate dehydrogenase, discharge, Clinical features, Laboratory, Spread, body mass index, Fever, Wuhan, Patient, Factors, age, hemoglobin, BMI, respiratory, disease, patients, clinical feature, association, ALT, Lactate, creatinine, COVID-19 patient, exposure to, alanine aminotransferase, body mass, retrospective cohort study, serum creatinine, acute respiratory syndrome, Acute liver injury, supplementary material, biochemical, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, independent risk factors, Alanine, high temperature, independent risk factor, illness onset, Zhejiang, men, duration of hospitalization, independent, radiological, Course, Result, analyzed, collected, significantly, proportion, diagnosed, elevated, median, discharged, 【제목키워드】 body mass index, multicenter, retrospective cohort study,